Skip to content

Observation on the Efficacy of Mucosal Invagination Anastomosis with Reinforced Posterior Wall in Preventing Anastomotic Leakage and Gastroesophageal Reflux After Esophageal Cancer Surgery

Observation on the Efficacy of Mucosal Invagination Anastomosis with Reinforced Posterior Wall in Preventing Anastomotic Leakage and Gastroesophageal Reflux After Esophageal Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124889
Enrollment
Unknown
Registered
2026-05-19
Start date
2024-08-25
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal tumor

Interventions

Observation group:None

Sponsors

Meishan City Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Those who meet the diagnostic criteria of the "Expert Consensus on Early Esophageal Cancer Screening and Endoscopic Diagnosis and Treatment in China", and have all been diagnosed with esophageal cancer by intraesophageal ultrasound and pathological biopsy; 2.All received thoracoscopic and laparoscopic radical resection of esophageal cancer treatment; 3.All medical records are complete. The survival period was all >=6 months.

Exclusion criteria

Exclusion criteria: 1.Those who experienced serious adverse events during the treatment period; 2.Those with mental illnesses, such as those with long-term consciousness disorders or abnormal mental states; 3.Those with severe digestive tract obstruction; 4.Those with cancer cell infiltration and metastasis.

Design outcomes

Primary

MeasureTime frame
Postoperative anastomotic leakage and recurrence rate of gastroesophageal reflux;

Countries

China

Contacts

Public ContactCui Hui

Meishan City People's Hospital

292246@163.com+86 28 38025162

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026